LOS ANGELES-A while paper from CB Richard Ellis analyzing the life sciences industry in the top nine US markets reveals that owners and occupiers of life-science properties face unprecedented leasing and investing challenges due to patent expirations over the next five years. The report, A Primer on Life Sciences Properties, based its findings on studies of the Boston, Los Angeles, New York/Northern New Jersey, Philadelphia/Southern New Jersey, Raleigh-Durham, NC, San Diego, San Francisco Bay Area, Seattle and Washington-Baltimore biotech and pharma-tech markets.

According to the report, which was prepared by members of CBRE’s Life Sciences Group, the major real estate challenge facing the industry is the fact the properties are among the most complex and expensive in the world, requiring extraordinarily high amount of capital to finance both construction and operation. Thomas Sullivan, senior vice president in CBRE’s Central New Jersey office and a senior member of the Life Sciences Group, says budgets for life-science buildings often run more than $1,000 a sf (see separate article).

The report points to several key concepts it calls critical for understanding the life-science industry, including the fact the two primary industry drivers are the increasing needs of an agingpopulation and overall consumer demand for improved healthcare. But despite the growing demand, CBRE says the industry’s high-risk character limits the number of investors willing to provide capital for early-stage development, with the largest share of investment going to acquisitions of mid- to late-stage products. Because the cost of developing new products is high, with prices for raw materials and labor increasing at a steep rate, life-science companies are looking for ways to contain costs and improve efficiencies without sacrificing safety and environmental concerns.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.